Global Topical Drug Delivery Market: Industry Analysis and Forecast (2019-2026) – By Product, Route of Administration, Facility of Use and Region.

Global Topical Drug Delivery Market: Industry Analysis and Forecast (2019-2026) – By Product, Route of Administration, Facility of Use and Region.

Market Scenario

Global Topical Drug Delivery Market was valued US$ XX Bn in 2018 and is expected to reach XX Bn by 2026, at a CAGR of 5.80 % during a forecast period. Topical medications are usually applied on body surfaces like skin or mucous membranes, which being reverse counterparts of systemic medications and products. These medications contain creams, foams, gels, lotions, ointments, and others. The increasing prevalence of skin disorders across the globe is one of the key drivers in the global topical drug delivery market. Growing incidence of diabetes across the globe is expected to increase the demand for topical drug delivery. Additionally, the growing incidence of burn injuries and the rising preference of topical drug delivery are projected to boost the market growth in the global topical drug delivery market. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. On the other hand, the negative impact on consumers owing to product recalls is expected to hamper the growth of the global topical drug delivery market during the forecast period. The global topical drug delivery market is estimated to experience XX% growth during the forecast period. Increasing demand for advanced and enhanced therapeutics is expected to offer lucrative opportunities. Furthermore, the growing number of approvals for new products for skin-related drug delivery is expected to boost the growth in the global topical drug delivery market. There have been major benefits in the topical and trans-dermal drug delivery systems, to target a specific site in the body. The administration of drugs through the skin is also accomplished to achieve controlled or continued drug delivery and this route can be discovered as an alternative to the oral route. The comfort of usage may reduce overall healthcare treatment costs. The dermal segment is expected to have a significant contribution to global topical drug delivery market growth, which is widely used and has certain benefits. North America region is estimated to hold the dominant position in the global topical drug delivery market. The growing prevalence of skin diseases, approvals, and introductions of innovative topical formulations and funding for the improvement of topical drugs are some of the driving factors behind the growth of the topical drug delivery market in the region. Furthermore, the Asia Pacific region is expected to grow at a XX % rate of CAGR during the forecast period. The growing aging population, increasing healthcare expenditure and disposable income, and rising focus of global pharmaceutical key players in emerging economies like India and China are expected to boost the growth in the global topical drug delivery market. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding dynamics, structure by analyzing the market segments and, project the global topical drug delivery market. The report also provides a clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global topical drug delivery market. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address the question of shareholders in arranging the efforts and investment in the near future to a particular market segment.

Scope of the Report for Global Topical Drug Delivery Market

Global Topical Drug Delivery Market, By Product

• Semi-Solid Formulations  Creams  Ointments  Lotions  Gels  Pastes • Liquid Formulations  Suspensions  Solutions • Solid Formulations  Powders  Suppositories • Transdermal Products  Transdermal Patches  Transdermal Semi-Solids

Global Topical Drug Delivery Market, By Route of Administration

• Dermal Drug Delivery • Ophthalmic Drug Delivery • Rectal Drug Delivery • Vaginal Drug Delivery • Nasal Drug Delivery

Global Topical Drug Delivery Market, By Facility of Use

• Home Care Settings • Hospitals and Clinics • Burn Centers • Other Facilities

Global Topical Drug Delivery Market, By Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Key players operating in Global Topical Drug Delivery Market

• Hisamitsu Pharmaceutical • Nestle SA • Novartis AG • Glenmark Pharmaceuticals • Cipla Inc. • Glaxosmithkline • MedPharm Group Ltd • Janssen Global Services • Bausch Health Companies • Pocono Coated Products LLC • Merck & Co. • Skinvisible Pharmaceuticals, Inc. • Bayer AG • Crescita Therapeutics Inc. • Galderma S.A. • Lohmann Therapie-Systeme AG • Mylan N.V. • Valeant Pharmaceuticals International, Inc.

Table of Contents

Global Topical Drug Delivery Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Topical Drug Delivery Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Topical Drug Delivery Market Analysis and Forecast 6.1. Global Topical Drug Delivery Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Topical Drug Delivery Market Analysis and Forecast, by Facility of Use 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Topical Drug Delivery Market Value Share Analysis, by Facility of Use 7.4. Global Topical Drug Delivery Market Size (US$ Bn) Forecast, by Facility of Use 7.5. Global Topical Drug Delivery Market Analysis, by Facility of Use 7.6. Global Topical Drug Delivery Market Attractiveness Analysis, by Facility of Use 8. Global Topical Drug Delivery Market Analysis and Forecast, by Route of Administration 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Topical Drug Delivery Market Value Share Analysis, by Route of Administration 8.4. Global Topical Drug Delivery Market Size (US$ Bn) Forecast, by Route of Administration 8.5. Global Topical Drug Delivery Market Analysis, by Route of Administration 8.6. Global Topical Drug Delivery Market Attractiveness Analysis, by Route of Administration 9. Global Topical Drug Delivery Market Analysis and Forecast, by Product 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Topical Drug Delivery Market Value Share Analysis, by Product 9.4. Global Topical Drug Delivery Market Size (US$ Bn) Forecast, by Product 9.5. Global Topical Drug Delivery Market Analysis, by Product 9.6. Global Topical Drug Delivery Market Attractiveness Analysis, by Product 10. Global Topical Drug Delivery Market Analysis, by Region 10.1. Global Topical Drug Delivery Market Value Share Analysis, by Region 10.2. Global Topical Drug Delivery Market Size (US$ Bn) Forecast, by Region 10.3. Global Topical Drug Delivery Market Attractiveness Analysis, by Region 11. North America Topical Drug Delivery Market Analysis 11.1. Key Findings 11.2. North America Topical Drug Delivery Market Overview 11.3. North America Topical Drug Delivery Market Value Share Analysis, by Facility of Use 11.4. North America Topical Drug Delivery Market Forecast, by Facility of Use 11.4.1. Home Care Settings 11.4.2. Hospitals and Clinics 11.4.3. Burn Centers 11.4.4. Other Facilities 11.5. North America Topical Drug Delivery Market Value Share Analysis, by Route of Administration 11.6. North America Topical Drug Delivery Market Forecast, by Route of Administration 11.6.1. Dermal Drug Delivery 11.6.2. Ophthalmic Drug Delivery 11.6.3. Rectal Drug Delivery 11.6.4. Vaginal Drug Delivery 11.6.5. Nasal Drug Delivery 11.7. North America Topical Drug Delivery Market Value Share Analysis, by Product 11.8. North America Topical Drug Delivery Market Forecast, by Product 11.8.1. Semi-Solid Formulations 11.8.1.1. Creams 11.8.1.2. Ointments 11.8.1.3. Lotions 11.8.1.4. Gels 11.8.1.5. Pastes 11.8.2. Liquid Formulations 11.8.2.1. Suspensions 11.8.2.2. Solutions 11.8.3. Solid Formulations 11.8.3.1. Powders 11.8.3.2. Suppositories 11.8.4. Transdermal Products 11.8.4.1. Transdermal Patches 11.8.4.2. Transdermal Semi-Solids 11.9. North America Topical Drug Delivery Market Value Share Analysis, by Country 11.10. North America Topical Drug Delivery Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Topical Drug Delivery Market Analysis, by Country 11.12. U.S. Topical Drug Delivery Market Forecast, by Facility of Use 11.12.1. Home Care Settings 11.12.2. Hospitals and Clinics 11.12.3. Burn Centers 11.12.4. Other Facilities 11.13. U.S. Topical Drug Delivery Market Forecast, by Route of Administration 11.13.1. Dermal Drug Delivery 11.13.2. Ophthalmic Drug Delivery 11.13.3. Rectal Drug Delivery 11.13.4. Vaginal Drug Delivery 11.13.5. Nasal Drug Delivery 11.14. U.S. Topical Drug Delivery Market Forecast, by Product 11.14.1. Semi-Solid Formulations 11.14.1.1. Creams 11.14.1.2. Ointments 11.14.1.3. Lotions 11.14.1.4. Gels 11.14.1.5. Pastes 11.14.2. Liquid Formulations 11.14.2.1. Suspensions 11.14.2.2. Solutions 11.14.3. Solid Formulations 11.14.3.1. Powders 11.14.3.2. Suppositories 11.14.4. Transdermal Products 11.14.4.1. Transdermal Patches 11.14.4.2. Transdermal Semi-Solids 11.15. Canada Topical Drug Delivery Market Forecast, by Facility of Use 11.15.1. Home Care Settings 11.15.2. Hospitals and Clinics 11.15.3. Burn Centers 11.15.4. Other Facilities 11.16. Canada Topical Drug Delivery Market Forecast, by Route of Administration 11.16.1. Dermal Drug Delivery 11.16.2. Ophthalmic Drug Delivery 11.16.3. Rectal Drug Delivery 11.16.4. Vaginal Drug Delivery 11.16.5. Nasal Drug Delivery 11.17. Canada Topical Drug Delivery Market Forecast, by Product 11.17.1. Semi-Solid Formulations 11.17.1.1. Creams 11.17.1.2. Ointments 11.17.1.3. Lotions 11.17.1.4. Gels 11.17.1.5. Pastes 11.17.2. Liquid Formulations 11.17.2.1. Suspensions 11.17.2.2. Solutions 11.17.3. Solid Formulations 11.17.3.1. Powders 11.17.3.2. Suppositories 11.17.4. Transdermal Products 11.17.4.1. Transdermal Patches 11.17.4.2. Transdermal Semi-Solids 11.18. North America Topical Drug Delivery Market Attractiveness Analysis 11.18.1. By Facility of Use 11.18.2. By Route of Administration 11.18.3. By Product 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Topical Drug Delivery Market Analysis 12.1. Key Findings 12.2. Europe Topical Drug Delivery Market Overview 12.3. Europe Topical Drug Delivery Market Value Share Analysis, by Facility of Use 12.4. Europe Topical Drug Delivery Market Forecast, by Facility of Use 12.4.1. Home Care Settings 12.4.2. Hospitals and Clinics 12.4.3. Burn Centers 12.4.4. Other Facilities 12.5. Europe Topical Drug Delivery Market Value Share Analysis, by Route of Administration 12.6. Europe Topical Drug Delivery Market Forecast, by Route of Administration 12.6.1. Dermal Drug Delivery 12.6.2. Ophthalmic Drug Delivery 12.6.3. Rectal Drug Delivery 12.6.4. Vaginal Drug Delivery 12.6.5. Nasal Drug Delivery 12.7. Europe Topical Drug Delivery Market Value Share Analysis, by Product 12.8. Europe Topical Drug Delivery Market Forecast, by Product 12.8.1. Semi-Solid Formulations 12.8.1.1. Creams 12.8.1.2. Ointments 12.8.1.3. Lotions 12.8.1.4. Gels 12.8.1.5. Pastes 12.8.2. Liquid Formulations 12.8.2.1. Suspensions 12.8.2.2. Solutions 12.8.3. Solid Formulations 12.8.3.1. Powders 12.8.3.2. Suppositories 12.8.4. Transdermal Products 12.8.4.1. Transdermal Patches 12.8.4.2. Transdermal Semi-Solids 12.9. Europe Topical Drug Delivery Market Value Share Analysis, by Country 12.10. Europe Topical Drug Delivery Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Topical Drug Delivery Market Analysis, by Country 12.12. Germany Topical Drug Delivery Market Forecast, by Facility of Use 12.12.1. Home Care Settings 12.12.2. Hospitals and Clinics 12.12.3. Burn Centers 12.12.4. Other Facilities 12.13. Germany Topical Drug Delivery Market Forecast, by Route of Administration 12.13.1. Dermal Drug Delivery 12.13.2. Ophthalmic Drug Delivery 12.13.3. Rectal Drug Delivery 12.13.4. Vaginal Drug Delivery 12.13.5. Nasal Drug Delivery 12.14. Germany Topical Drug Delivery Market Forecast, by Product 12.14.1. Semi-Solid Formulations 12.14.1.1. Creams 12.14.1.2. Ointments 12.14.1.3. Lotions 12.14.1.4. Gels 12.14.1.5. Pastes 12.14.2. Liquid Formulations 12.14.2.1. Suspensions 12.14.2.2. Solutions 12.14.3. Solid Formulations 12.14.3.1. Powders 12.14.3.2. Suppositories 12.14.4. Transdermal Products 12.14.4.1. Transdermal Patches 12.14.4.2. Transdermal Semi-Solids 12.15. U.K. Topical Drug Delivery Market Forecast, by Facility of Use 12.15.1. Home Care Settings 12.15.2. Hospitals and Clinics 12.15.3. Burn Centers 12.15.4. Other Facilities 12.16. U.K. Topical Drug Delivery Market Forecast, by Route of Administration 12.16.1. Dermal Drug Delivery 12.16.2. Ophthalmic Drug Delivery 12.16.3. Rectal Drug Delivery 12.16.4. Vaginal Drug Delivery 12.16.5. Nasal Drug Delivery 12.17. U.K. Topical Drug Delivery Market Forecast, by Product 12.17.1. Semi-Solid Formulations 12.17.1.1. Creams 12.17.1.2. Ointments 12.17.1.3. Lotions 12.17.1.4. Gels 12.17.1.5. Pastes 12.17.2. Liquid Formulations 12.17.2.1. Suspensions 12.17.2.2. Solutions 12.17.3. Solid Formulations 12.17.3.1. Powders 12.17.3.2. Suppositories 12.17.4. Transdermal Products 12.17.4.1. Transdermal Patches 12.17.4.2. Transdermal Semi-Solids 12.18. France Topical Drug Delivery Market Forecast, by Facility of Use 12.18.1. Home Care Settings 12.18.2. Hospitals and Clinics 12.18.3. Burn Centers 12.18.4. Other Facilities 12.19. France Topical Drug Delivery Market Forecast, by Route of Administration 12.19.1. Dermal Drug Delivery 12.19.2. Ophthalmic Drug Delivery 12.19.3. Rectal Drug Delivery 12.19.4. Vaginal Drug Delivery 12.19.5. Nasal Drug Delivery 12.20. France Topical Drug Delivery Market Forecast, by Product 12.20.1. Semi-Solid Formulations 12.20.1.1. Creams 12.20.1.2. Ointments 12.20.1.3. Lotions 12.20.1.4. Gels 12.20.1.5. Pastes 12.20.2. Liquid Formulations 12.20.2.1. Suspensions 12.20.2.2. Solutions 12.20.3. Solid Formulations 12.20.3.1. Powders 12.20.3.2. Suppositories 12.20.4. Transdermal Products 12.20.4.1. Transdermal Patches 12.20.4.2. Transdermal Semi-Solids 12.21. Italy Topical Drug Delivery Market Forecast, by Facility of Use 12.21.1. Home Care Settings 12.21.2. Hospitals and Clinics 12.21.3. Burn Centers 12.21.4. Other Facilities 12.22. Italy Topical Drug Delivery Market Forecast, by Route of Administration 12.22.1. Dermal Drug Delivery 12.22.2. Ophthalmic Drug Delivery 12.22.3. Rectal Drug Delivery 12.22.4. Vaginal Drug Delivery 12.22.5. Nasal Drug Delivery 12.23. Italy Topical Drug Delivery Market Forecast, by Product 12.23.1. Semi-Solid Formulations 12.23.1.1. Creams 12.23.1.2. Ointments 12.23.1.3. Lotions 12.23.1.4. Gels 12.23.1.5. Pastes 12.23.2. Liquid Formulations 12.23.2.1. Suspensions 12.23.2.2. Solutions 12.23.3. Solid Formulations 12.23.3.1. Powders 12.23.3.2. Suppositories 12.23.4. Transdermal Products 12.23.4.1. Transdermal Patches 12.23.4.2. Transdermal Semi-Solids 12.24. Spain Topical Drug Delivery Market Forecast, by Facility of Use 12.24.1. Home Care Settings 12.24.2. Hospitals and Clinics 12.24.3. Burn Centers 12.24.4. Other Facilities 12.25. Spain Topical Drug Delivery Market Forecast, by Route of Administration 12.25.1. Dermal Drug Delivery 12.25.2. Ophthalmic Drug Delivery 12.25.3. Rectal Drug Delivery 12.25.4. Vaginal Drug Delivery 12.25.5. Nasal Drug Delivery 12.26. Spain Topical Drug Delivery Market Forecast, by Product 12.26.1. Semi-Solid Formulations 12.26.1.1. Creams 12.26.1.2. Ointments 12.26.1.3. Lotions 12.26.1.4. Gels 12.26.1.5. Pastes 12.26.2. Liquid Formulations 12.26.2.1. Suspensions 12.26.2.2. Solutions 12.26.3. Solid Formulations 12.26.3.1. Powders 12.26.3.2. Suppositories 12.26.4. Transdermal Products 12.26.4.1. Transdermal Patches 12.26.4.2. Transdermal Semi-Solids 12.27. Rest of Europe Topical Drug Delivery Market Forecast, by Facility of Use 12.27.1. Home Care Settings 12.27.2. Hospitals and Clinics 12.27.3. Burn Centers 12.27.4. Other Facilities 12.28. Rest of Europe Topical Drug Delivery Market Forecast, by Route of Administration 12.28.1. Dermal Drug Delivery 12.28.2. Ophthalmic Drug Delivery 12.28.3. Rectal Drug Delivery 12.28.4. Vaginal Drug Delivery 12.28.5. Nasal Drug Delivery 12.29. Rest Of Europe Topical Drug Delivery Market Forecast, by Product 12.29.1. Semi-Solid Formulations 12.29.1.1. Creams 12.29.1.2. Ointments 12.29.1.3. Lotions 12.29.1.4. Gels 12.29.1.5. Pastes 12.29.2. Liquid Formulations 12.29.2.1. Suspensions 12.29.2.2. Solutions 12.29.3. Solid Formulations 12.29.3.1. Powders 12.29.3.2. Suppositories 12.29.4. Transdermal Products 12.29.4.1. Transdermal Patches 12.29.4.2. Transdermal Semi-Solids 12.30. Europe Topical Drug Delivery Market Attractiveness Analysis 12.30.1. By Facility of Use 12.30.2. By Route of Administration 12.30.3. By Product 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Topical Drug Delivery Market Analysis 13.1. Key Findings 13.2. Asia Pacific Topical Drug Delivery Market Overview 13.3. Asia Pacific Topical Drug Delivery Market Value Share Analysis, by Facility of Use 13.4. Asia Pacific Topical Drug Delivery Market Forecast, by Facility of Use 13.4.1. Home Care Settings 13.4.2. Hospitals and Clinics 13.4.3. Burn Centers 13.4.4. Other Facilities 13.5. Asia Pacific Topical Drug Delivery Market Value Share Analysis, by Route of Administration 13.6. Asia Pacific Topical Drug Delivery Market Forecast, by Route of Administration 13.6.1. Dermal Drug Delivery 13.6.2. Ophthalmic Drug Delivery 13.6.3. Rectal Drug Delivery 13.6.4. Vaginal Drug Delivery 13.6.5. Nasal Drug Delivery 13.7. Asia Pacific Topical Drug Delivery Market Value Share Analysis, by Product 13.8. Asia Pacific Topical Drug Delivery Market Forecast, by Product 13.8.1. Semi-Solid Formulations 13.8.1.1. Creams 13.8.1.2. Ointments 13.8.1.3. Lotions 13.8.1.4. Gels 13.8.1.5. Pastes 13.8.2. Liquid Formulations 13.8.2.1. Suspensions 13.8.2.2. Solutions 13.8.3. Solid Formulations 13.8.3.1. Powders 13.8.3.2. Suppositories 13.8.4. Transdermal Products 13.8.4.1. Transdermal Patches 13.8.4.2. Transdermal Semi-Solids 13.9. Asia Pacific Topical Drug Delivery Market Value Share Analysis, by Country 13.10. Asia Pacific Topical Drug Delivery Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Topical Drug Delivery Market Analysis, by Country 13.12. China Topical Drug Delivery Market Forecast, by Facility of Use 13.12.1. Home Care Settings 13.12.2. Hospitals and Clinics 13.12.3. Burn Centers 13.12.4. Other Facilities 13.13. China Topical Drug Delivery Market Forecast, by Route of Administration 13.13.1. Dermal Drug Delivery 13.13.2. Ophthalmic Drug Delivery 13.13.3. Rectal Drug Delivery 13.13.4. Vaginal Drug Delivery 13.13.5. Nasal Drug Delivery 13.14. China Topical Drug Delivery Market Forecast, by Product 13.14.1. Semi-Solid Formulations 13.14.1.1. Creams 13.14.1.2. Ointments 13.14.1.3. Lotions 13.14.1.4. Gels 13.14.1.5. Pastes 13.14.2. Liquid Formulations 13.14.2.1. Suspensions 13.14.2.2. Solutions 13.14.3. Solid Formulations 13.14.3.1. Powders 13.14.3.2. Suppositories 13.14.4. Transdermal Products 13.14.4.1. Transdermal Patches 13.14.4.2. Transdermal Semi-Solids 13.15. India Topical Drug Delivery Market Forecast, by Facility of Use 13.15.1. Home Care Settings 13.15.2. Hospitals and Clinics 13.15.3. Burn Centers 13.15.4. Other Facilities 13.16. India Topical Drug Delivery Market Forecast, by Route of Administration 13.16.1. Dermal Drug Delivery 13.16.2. Ophthalmic Drug Delivery 13.16.3. Rectal Drug Delivery 13.16.4. Vaginal Drug Delivery 13.16.5. Nasal Drug Delivery 13.17. India Topical Drug Delivery Market Forecast, by Product 13.17.1. Semi-Solid Formulations 13.17.1.1. Creams 13.17.1.2. Ointments 13.17.1.3. Lotions 13.17.1.4. Gels 13.17.1.5. Pastes 13.17.2. Liquid Formulations 13.17.2.1. Suspensions 13.17.2.2. Solutions 13.17.3. Solid Formulations 13.17.3.1. Powders 13.17.3.2. Suppositories 13.17.4. Transdermal Products 13.17.4.1. Transdermal Patches 13.17.4.2. Transdermal Semi-Solids 13.18. Japan Topical Drug Delivery Market Forecast, by Facility of Use 13.18.1. Home Care Settings 13.18.2. Hospitals and Clinics 13.18.3. Burn Centers 13.18.4. Other Facilities 13.19. Japan Topical Drug Delivery Market Forecast, by Route of Administration 13.19.1. Dermal Drug Delivery 13.19.2. Ophthalmic Drug Delivery 13.19.3. Rectal Drug Delivery 13.19.4. Vaginal Drug Delivery 13.19.5. Nasal Drug Delivery 13.20. Japan Topical Drug Delivery Market Forecast, by Product 13.20.1. Semi-Solid Formulations 13.20.1.1. Creams 13.20.1.2. Ointments 13.20.1.3. Lotions 13.20.1.4. Gels 13.20.1.5. Pastes 13.20.2. Liquid Formulations 13.20.2.1. Suspensions 13.20.2.2. Solutions 13.20.3. Solid Formulations 13.20.3.1. Powders 13.20.3.2. Suppositories 13.20.4. Transdermal Products 13.20.4.1. Transdermal Patches 13.20.4.2. Transdermal Semi-Solids 13.21. ASEAN Topical Drug Delivery Market Forecast, by Facility of Use 13.21.1. Home Care Settings 13.21.2. Hospitals and Clinics 13.21.3. Burn Centers 13.21.4. Other Facilities 13.22. ASEAN Topical Drug Delivery Market Forecast, by Route of Administration 13.22.1. Dermal Drug Delivery 13.22.2. Ophthalmic Drug Delivery 13.22.3. Rectal Drug Delivery 13.22.4. Vaginal Drug Delivery 13.22.5. Nasal Drug Delivery 13.23. ASEAN Topical Drug Delivery Market Forecast, by Product 13.23.1. Semi-Solid Formulations 13.23.1.1. Creams 13.23.1.2. Ointments 13.23.1.3. Lotions 13.23.1.4. Gels 13.23.1.5. Pastes 13.23.2. Liquid Formulations 13.23.2.1. Suspensions 13.23.2.2. Solutions 13.23.3. Solid Formulations 13.23.3.1. Powders 13.23.3.2. Suppositories 13.23.4. Transdermal Products 13.23.4.1. Transdermal Patches 13.23.4.2. Transdermal Semi-Solids 13.24. Rest of Asia Pacific Topical Drug Delivery Market Forecast, by Facility of Use 13.24.1. Home Care Settings 13.24.2. Hospitals and Clinics 13.24.3. Burn Centers 13.24.4. Other Facilities 13.25. Rest of Asia Pacific Topical Drug Delivery Market Forecast, by Route of Administration 13.25.1. Dermal Drug Delivery 13.25.2. Ophthalmic Drug Delivery 13.25.3. Rectal Drug Delivery 13.25.4. Vaginal Drug Delivery 13.25.5. Nasal Drug Delivery 13.26. Rest of Asia Pacific Topical Drug Delivery Market Forecast, by Product 13.26.1. Semi-Solid Formulations 13.26.1.1. Creams 13.26.1.2. Ointments 13.26.1.3. Lotions 13.26.1.4. Gels 13.26.1.5. Pastes 13.26.2. Liquid Formulations 13.26.2.1. Suspensions 13.26.2.2. Solutions 13.26.3. Solid Formulations 13.26.3.1. Powders 13.26.3.2. Suppositories 13.26.4. Transdermal Products 13.26.4.1. Transdermal Patches 13.26.4.2. Transdermal Semi-Solids 13.27. Asia Pacific Topical Drug Delivery Market Attractiveness Analysis 13.27.1. By Facility of Use 13.27.2. By Route of Administration 13.27.3. By Product 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Topical Drug Delivery Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Topical Drug Delivery Market Overview 14.3. Middle East & Africa Topical Drug Delivery Market Value Share Analysis, by Facility of Use 14.4. Middle East & Africa Topical Drug Delivery Market Forecast, by Facility of Use 14.4.1. Home Care Settings 14.4.2. Hospitals and Clinics 14.4.3. Burn Centers 14.4.4. Other Facilities 14.5. Middle East & Africa Topical Drug Delivery Market Value Share Analysis, by Route of Administration 14.6. Middle East & Africa Topical Drug Delivery Market Forecast, by Route of Administration 14.6.1. Dermal Drug Delivery 14.6.2. Ophthalmic Drug Delivery 14.6.3. Rectal Drug Delivery 14.6.4. Vaginal Drug Delivery 14.6.5. Nasal Drug Delivery 14.7. Middle East & Africa Topical Drug Delivery Market Value Share Analysis, by Product 14.8. Middle East & Africa Topical Drug Delivery Market Forecast, by Product 14.8.1. Semi-Solid Formulations 14.8.1.1. Creams 14.8.1.2. Ointments 14.8.1.3. Lotions 14.8.1.4. Gels 14.8.1.5. Pastes 14.8.2. Liquid Formulations 14.8.2.1. Suspensions 14.8.2.2. Solutions 14.8.3. Solid Formulations 14.8.3.1. Powders 14.8.3.2. Suppositories 14.8.4. Transdermal Products 14.8.4.1. Transdermal Patches 14.8.4.2. Transdermal Semi-Solids 14.9. Middle East & Africa Topical Drug Delivery Market Value Share Analysis, by Country 14.10. Middle East & Africa Topical Drug Delivery Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Topical Drug Delivery Market Analysis, by Country 14.12. GCC Topical Drug Delivery Market Forecast, by Facility of Use 14.12.1. Home Care Settings 14.12.2. Hospitals and Clinics 14.12.3. Burn Centers 14.12.4. Other Facilities 14.13. GCC Topical Drug Delivery Market Forecast, by Route of Administration 14.13.1. Dermal Drug Delivery 14.13.2. Ophthalmic Drug Delivery 14.13.3. Rectal Drug Delivery 14.13.4. Vaginal Drug Delivery 14.13.5. Nasal Drug Delivery 14.14. GCC Topical Drug Delivery Market Forecast, by Product 14.14.1. Semi-Solid Formulations 14.14.1.1. Creams 14.14.1.2. Ointments 14.14.1.3. Lotions 14.14.1.4. Gels 14.14.1.5. Pastes 14.14.2. Liquid Formulations 14.14.2.1. Suspensions 14.14.2.2. Solutions 14.14.3. Solid Formulations 14.14.3.1. Powders 14.14.3.2. Suppositories 14.14.4. Transdermal Products 14.14.4.1. Transdermal Patches 14.14.4.2. Transdermal Semi-Solids 14.15. South Africa Topical Drug Delivery Market Forecast, by Facility of Use 14.15.1. Home Care Settings 14.15.2. Hospitals and Clinics 14.15.3. Burn Centers 14.15.4. Other Facilities 14.16. South Africa Topical Drug Delivery Market Forecast, by Route of Administration 14.16.1. Dermal Drug Delivery 14.16.2. Ophthalmic Drug Delivery 14.16.3. Rectal Drug Delivery 14.16.4. Vaginal Drug Delivery 14.16.5. Nasal Drug Delivery 14.17. South Africa Topical Drug Delivery Market Forecast, by Product 14.17.1. Semi-Solid Formulations 14.17.1.1. Creams 14.17.1.2. Ointments 14.17.1.3. Lotions 14.17.1.4. Gels 14.17.1.5. Pastes 14.17.2. Liquid Formulations 14.17.2.1. Suspensions 14.17.2.2. Solutions 14.17.3. Solid Formulations 14.17.3.1. Powders 14.17.3.2. Suppositories 14.17.4. Transdermal Products 14.17.4.1. Transdermal Patches 14.17.4.2. Transdermal Semi-Solids 14.18. Rest of Middle East & Africa Topical Drug Delivery Market Forecast, by Facility of Use 14.18.1. Home Care Settings 14.18.2. Hospitals and Clinics 14.18.3. Burn Centers 14.18.4. Other Facilities 14.19. Rest of Middle East & Africa Topical Drug Delivery Market Forecast, by Route of Administration 14.19.1. Dermal Drug Delivery 14.19.2. Ophthalmic Drug Delivery 14.19.3. Rectal Drug Delivery 14.19.4. Vaginal Drug Delivery 14.19.5. Nasal Drug Delivery 14.20. Rest of Middle East & Africa Topical Drug Delivery Market Forecast, by Product 14.20.1. Semi-Solid Formulations 14.20.1.1. Creams 14.20.1.2. Ointments 14.20.1.3. Lotions 14.20.1.4. Gels 14.20.1.5. Pastes 14.20.2. Liquid Formulations 14.20.2.1. Suspensions 14.20.2.2. Solutions 14.20.3. Solid Formulations 14.20.3.1. Powders 14.20.3.2. Suppositories 14.20.4. Transdermal Products 14.20.4.1. Transdermal Patches 14.20.4.2. Transdermal Semi-Solids 14.21. Middle East & Africa Topical Drug Delivery Market Attractiveness Analysis 14.21.1. By Facility of Use 14.21.2. By Route of Administration 14.21.3. By Product 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Topical Drug Delivery Market Analysis 15.1. Key Findings 15.2. South America Topical Drug Delivery Market Overview 15.3. South America Topical Drug Delivery Market Value Share Analysis, by Facility of Use 15.4. South America Topical Drug Delivery Market Forecast, by Facility of Use 15.4.1. Home Care Settings 15.4.2. Hospitals and Clinics 15.4.3. Burn Centers 15.4.4. Other Facilities 15.5. South America Topical Drug Delivery Market Value Share Analysis, by Route of Administration 15.6. South America Topical Drug Delivery Market Forecast, by Route of Administration 15.6.1. Dermal Drug Delivery 15.6.2. Ophthalmic Drug Delivery 15.6.3. Rectal Drug Delivery 15.6.4. Vaginal Drug Delivery 15.6.5. Nasal Drug Delivery 15.7. South America Topical Drug Delivery Market Value Share Analysis, by Product 15.8. South America Topical Drug Delivery Market Forecast, by Product 15.8.1. Semi-Solid Formulations 15.8.1.1. Creams 15.8.1.2. Ointments 15.8.1.3. Lotions 15.8.1.4. Gels 15.8.1.5. Pastes 15.8.2. Liquid Formulations 15.8.2.1. Suspensions 15.8.2.2. Solutions 15.8.3. Solid Formulations 15.8.3.1. Powders 15.8.3.2. Suppositories 15.8.4. Transdermal Products 15.8.4.1. Transdermal Patches 15.8.4.2. Transdermal Semi-Solids 15.9. South America Topical Drug Delivery Market Value Share Analysis, by Country 15.10. South America Topical Drug Delivery Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Topical Drug Delivery Market Analysis, by Country 15.12. Brazil Topical Drug Delivery Market Forecast, by Facility of Use 15.12.1. Home Care Settings 15.12.2. Hospitals and Clinics 15.12.3. Burn Centers 15.12.4. Other Facilities 15.13. Brazil Topical Drug Delivery Market Forecast, by Route of Administration 15.13.1. Dermal Drug Delivery 15.13.2. Ophthalmic Drug Delivery 15.13.3. Rectal Drug Delivery 15.13.4. Vaginal Drug Delivery 15.13.5. Nasal Drug Delivery 15.14. Brazil Topical Drug Delivery Market Forecast, by Product 15.14.1. Semi-Solid Formulations 15.14.1.1. Creams 15.14.1.2. Ointments 15.14.1.3. Lotions 15.14.1.4. Gels 15.14.1.5. Pastes 15.14.2. Liquid Formulations 15.14.2.1. Suspensions 15.14.2.2. Solutions 15.14.3. Solid Formulations 15.14.3.1. Powders 15.14.3.2. Suppositories 15.14.4. Transdermal Products 15.14.4.1. Transdermal Patches 15.14.4.2. Transdermal Semi-Solids 15.15. Mexico Topical Drug Delivery Market Forecast, by Facility of Use 15.15.1. Home Care Settings 15.15.2. Hospitals and Clinics 15.15.3. Burn Centers 15.15.4. Other Facilities 15.16. Mexico Topical Drug Delivery Market Forecast, by Route of Administration 15.16.1. Dermal Drug Delivery 15.16.2. Ophthalmic Drug Delivery 15.16.3. Rectal Drug Delivery 15.16.4. Vaginal Drug Delivery 15.16.5. Nasal Drug Delivery 15.17. Mexico Topical Drug Delivery Market Forecast, by Product 15.17.1. Semi-Solid Formulations 15.17.1.1. Creams 15.17.1.2. Ointments 15.17.1.3. Lotions 15.17.1.4. Gels 15.17.1.5. Pastes 15.17.2. Liquid Formulations 15.17.2.1. Suspensions 15.17.2.2. Solutions 15.17.3. Solid Formulations 15.17.3.1. Powders 15.17.3.2. Suppositories 15.17.4. Transdermal Products 15.17.4.1. Transdermal Patches 15.17.4.2. Transdermal Semi-Solids 15.18. Rest of South America Topical Drug Delivery Market Forecast, by Facility of Use 15.18.1. Home Care Settings 15.18.2. Hospitals and Clinics 15.18.3. Burn Centers 15.18.4. Other Facilities 15.19. Rest of South America Topical Drug Delivery Market Forecast, by Route of Administration 15.19.1. Dermal Drug Delivery 15.19.2. Ophthalmic Drug Delivery 15.19.3. Rectal Drug Delivery 15.19.4. Vaginal Drug Delivery 15.19.5. Nasal Drug Delivery 15.20. Rest of South America Topical Drug Delivery Market Forecast, by Product 15.20.1. Semi-Solid Formulations 15.20.1.1. Creams 15.20.1.2. Ointments 15.20.1.3. Lotions 15.20.1.4. Gels 15.20.1.5. Pastes 15.20.2. Liquid Formulations 15.20.2.1. Suspensions 15.20.2.2. Solutions 15.20.3. Solid Formulations 15.20.3.1. Powders 15.20.3.2. Suppositories 15.20.4. Transdermal Products 15.20.4.1. Transdermal Patches 15.20.4.2. Transdermal Semi-Solids 15.21. South America Topical Drug Delivery Market Attractiveness Analysis 15.21.1. By Facility of Use 15.21.2. By Route of Administration 15.21.3. By Product 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Hisamitsu Pharmaceutical 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Developing Footprint 16.3.2. Nestle SA 16.3.3. Novartis AG 16.3.4. Glen mark Pharmaceuticals 16.3.5. Cipla Inc. 16.3.6. Glaxosmithkline 16.3.7. MedPharm Group Ltd 16.3.8. Janssen Global Services 16.3.9. Bausch Health Companies 16.3.10. Pocono Coated Products LLC 16.3.11. Merck & Co. 16.3.12. Skinvisible Pharmaceuticals, Inc. 16.3.13. Bayer AG 16.3.14. Crescita Therapeutics Inc. 16.3.15. Galderma S.A. 16.3.16. Lohmann Therapie-Systeme AG 16.3.17. Mylan N.V. 16.3.18. Valeant Pharmaceuticals International, Inc. 17. Primary Key Insights

About This Report

Report ID33725
Category Healthcare
Published DateAug 2019
No of Pages189
Contact Us
Call Now